INSILICO(03696),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

03696 INSILICO

Noon Closed 04-24 11:59:47

69.850

-1.700

-2.38%

High72.950	Low68.400	Vol1.48M
Open72.950	D1 Closing71.550	Amplitude6.36%
Mkt Cap39.93B	Tradable Cap39.93B	Total Shares571.62M
T/O103.64M	T/O Rate0.26%	Tradable Shares571.62M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"03696","market":"HK","secType":"STK","nameCN":"INSILICO","latestPrice":69.85,"timestamp":1777003187761,"preClose":71.55,"halted":0,"volume":1480513,"delay":0,"changeRate":-0.023759608665269084,"floatShares":571622000,"shares":571622000,"eps":-35.10036510647633,"marketStatus":"Noon Closed","change":-1.7,"latestTime":"04-24 11:59:47","open":72.95,"high":72.95,"low":68.4,"amount":103639140,"amplitude":0.063592,"askPrice":70.1,"askSize":2000,"bidPrice":69.85,"bidSize":1500,"shortable":3,"etf":0,"ttmEps":-37.52918501339769,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1777006800000},"marketStatusCode":3,"adr":0,"listingDate":1767024000000,"exchange":"SEHK","adjPreClose":71.55,"openAndCloseTimeList":[[1776994200000,1777003200000],[1777006800000,1777017600000]],"volumeRatio":0.62191,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03696","defaultTab":"news","newsList":[{"id":"2629893818","title":"Insilico Medicine Nominates AI-Developed Brain Cancer Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2629893818","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629893818?lang=en_us&edition=fundamental","pubTime":"2026-04-24 09:54","pubTimestamp":1776995667,"startTime":"0","endTime":"0","summary":"Insilico Medicine  has nominated a new preclinical drug candidate for glioblastoma using its artificial intelligence platform, according to a Friday Hong Kong bourse filing.The candidate, ISM0387, was developed by the company's United Arab Emirates team using its Pharma.AI system and progressed from design to optimization in under 12 months.Insilico said the drug showed improved activity, selectivity, and brain penetration in early studies, with potential as a treatment for brain cancer.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AIPO","ARTY","BK1141","03696","AGIX","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629378898","title":"BRIEF-Insilico Medicine Cayman Topco Nominates ISM0387 As Preclinical Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2629378898","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629378898?lang=en_us&edition=fundamental","pubTime":"2026-04-24 09:28","pubTimestamp":1776994089,"startTime":"0","endTime":"0","summary":"BRIEF-Insilico Medicine Cayman Topco Nominates ISM0387 As Preclinical CandidateApril 24 (Reuters) - Insilico Medicine Cayman TopCo 3696.HK:NOMINATES ISM0387 AS PRECLINICAL CANDIDATEFurther company coverage: 3696.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nFWN41619T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198852916","title":"Insilico's UAE Team Selects First AI-Designed Preclinical Candidate for Regional Drug Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1198852916","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198852916?lang=en_us&edition=fundamental","pubTime":"2026-04-24 08:14","pubTimestamp":1776989694,"startTime":"0","endTime":"0","summary":"Insilico has officially nominated ISM0387, a novel MTA-cooperative PRMT5 inhibitor, as a preclinical candidate drug. This molecule was discovered locally by the company's UAE team using its...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTY","03696","AGIX","AIPO","CHAT","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183745135","title":"Insilico Announces 30th AI-Driven Preclinical Candidate ISM0387 Targeting Glioblastoma","url":"https://stock-news.laohu8.com/highlight/detail?id=1183745135","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183745135?lang=en_us&edition=fundamental","pubTime":"2026-04-24 08:04","pubTimestamp":1776989071,"startTime":"0","endTime":"0","summary":"Insilico Medicine Cayman TopCo (Insilico) disclosed that its UAE research team has advanced ISM0387, an MTA-cooperative PRMT5 inhibitor, to pre-clinical candidate status. The molecule was generated...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629623318","title":"Insilico Medicine nominates PRMT5 inhibitor ISM0387 as preclinical candidate for glioblastoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2629623318","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629623318?lang=en_us&edition=fundamental","pubTime":"2026-04-24 08:00","pubTimestamp":1776988855,"startTime":"0","endTime":"0","summary":"Insilico Medicine nominated ISM0387, an MTA-cooperative PRMT5 inhibitor, as a preclinical candidate discovered by its UAE team using Pharma.AI.Program completed early discovery workflow in UAE in less than 12 months, including hit generation within 30 days.Lead optimization finished within 6 months, signaling faster cycle times for AI-driven R&D execution.ISM0387 showed improved in vitro activity and selectivity, with enhanced brain penetration.Candidate is positioned as a potential glioblastoma treatment; nomination marked Insilico Medicine’s 30th AI-supported preclinical candidate.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insilico Medicine Cayman Topco published the original content used to generate this news brief via IIS, the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nNDLbsYB9r:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180995486","title":"INSILICO Stock Surges Over 10% After Establishing First Industry Longevity Committee","url":"https://stock-news.laohu8.com/highlight/detail?id=1180995486","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180995486?lang=en_us&edition=fundamental","pubTime":"2026-04-22 11:10","pubTimestamp":1776827458,"startTime":"0","endTime":"0","summary":"INSILICO (03696) saw its gains expand to over 10%. At the time of writing, the stock was up 9.73%, trading at HK$75, with a turnover of HK$318 million. The company announced the formation of the...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989771016.USD","LU0109391861.USD","SGXZ51526630.SGD","LU0417517546.SGD","IE00BK4W5L77.USD","LU1983299246.USD","LU1974910355.USD","LU2756315318.SGD","SG9999015986.USD","LU0320765992.SGD","LU1093756325.SGD","LU0114720955.EUR","LU2089284900.SGD","LU1988902786.USD","ELIS","IE00BKPKM429.USD","LU2112291526.USD","LU0316494557.USD","LU1035775433.USD","LU2236285917.USD","LU2237443895.HKD","LU0466842654.USD","LU0820562030.AUD","LU2461242641.AUD","IE00BFSS8Q28.SGD","IE0004445015.USD","LU2756315664.SGD","LU0289739699.SGD","LU0225283273.USD","LU0203202063.USD","BK4516","LU2087625088.SGD","LU0238689110.USD","LU0058720904.USD","LU0198837287.USD","LU0456855351.SGD","LU2357305700.SGD","SG9999015952.SGD","LU2471134523.USD","LU0353189763.USD","LU2264538146.SGD","LU0109394709.USD","BK4581","LU1868836914.USD","LU1291159041.SGD","LU0820561818.USD","LU2168564149.EUR","LU2237443978.SGD","IE00BJLML261.HKD","BK4007","IE00BJJMRZ35.SGD","LU0256863811.USD","LU1057294990.SGD","LU2361044865.SGD","SGXZ57979304.SGD","SG9999014898.SGD","LU0385154629.USD","LU1064131342.USD","LU1023059063.AUD","BK1141","LU2896262040.SGD","LU0471298777.SGD","LU0689472784.USD","LU2471134796.USD","LU2106854487.HKD","LU2491050154.USD","IE00B7KXQ091.USD","BK4599","IE00BN29S564.USD","LU0889565916.HKD","LU0708995401.HKD","LU1093756168.USD","LU2552382215.SGD","LU1917777945.USD","IE0001KFT4U8.USD","LU2361045086.USD","LU1232071149.USD","LLYX","LU1804176565.USD","IE00B4R5TH58.HKD","IE00B775H168.HKD","SGXZ81514606.USD","LU2028103732.USD","LU2089283258.USD","LU2750360997.AUD","LU0097036916.USD","SG9999001176.USD","LU2746668974.SGD","IE00BFTCPJ56.SGD","IE0004445239.USD","SG9999014914.USD","SGXZ31699556.SGD","IE0002141913.USD","LU0323591593.USD","LU2417539215.USD","LU2237443382.USD","SG9999015945.SGD","IE00B1XK9C88.USD","IE00B2B36J28.USD","LU0882574139.USD","LU0079474960.USD","LU2237443622.USD","SG9999001176.SGD","LU1145028129.USD","LU0823416689.USD","LU1127390331.HKD","LU2552382132.HKD","SG9999014906.USD","LU0882574055.USD","LU2468319806.SGD","LLYZ","LU2168564222.USD","LU2237443549.SGD","LU0210536198.USD","LU0354030511.USD","BK4534","LU2456880835.USD","ELIL","LU0266013472.USD","LU2360106947.USD","SG9999014880.SGD","LU0006306889.USD","LU1366192091.USD","LU2168564065.EUR","LLII","LU0234572021.USD","LU2324357040.USD","LU2108987350.USD","LU2491050071.SGD","LU1720051108.HKD","LU1868836591.USD","LU2089984988.USD","GB00BDT5M118.USD","LU1548497426.USD","LU0106261372.USD","LU0122379950.USD","LU2552382058.USD","LU1868836757.USD","LU0096364046.USD","LU0823434740.USD","LU1623119135.USD","LU1712237335.SGD","LU0820561909.HKD","IE00BKDWB100.SGD","LU2211815571.USD","LU1551013342.USD","BK4588","IE0005OL40V9.USD","LU0354030438.USD","LU0640476718.USD","LU1267930730.SGD","LU2237438978.USD","LU2746668461.USD","LU0353189680.USD","LU0158827948.USD","LU2271345857.HKD","LU0203201768.USD","LU0943347566.SGD","SG9999018865.SGD","LU0432979614.USD","IE00BK4W5M84.HKD","LU0256863902.USD","LU1868837136.USD","IE00BJJMRY28.SGD","LU2023250504.SGD","LU2168563687.JPY","IE00B1BXHZ80.USD","03696","LU0320765059.SGD","LU2023250330.USD","LU2471134879.HKD","LU2750360641.GBP","LU1814569148.SGD","LU2237443465.HKD","LU2491049909.HKD","IE00B4JS1V06.HKD","BK4585","LU2168564495.EUR","LU1069344957.HKD","LU1629891620.HKD","LU1868837300.USD","LU0672654240.SGD","LU0158827781.USD","LU0786609619.USD","IE00BFSS7M15.SGD","SG9999017495.SGD","LU2602419157.SGD","LU2462157665.USD","SG9999015978.USD","LU2361044949.HKD","LU2213496289.HKD","LU1551013425.SGD","LU2471134952.CNY","LU0061475181.USD","LU1323610961.USD","LU2111349929.HKD","LU2265009873.SGD","LU0787776722.HKD","SG9999013999.USD","IE00BJT1NW94.SGD","SGXZ99366536.SGD","LU2063271972.USD","LU0471298694.HKD","IE0009355771.USD","LU0823434583.USD","LU0683600562.USD","LU2023251221.USD","IE00BWXC8680.SGD","LU1061106388.HKD","LU1280957306.USD","LU1720051017.SGD","SG9999018857.SGD","IE00BJJMRX11.SGD","LU0133085943.USD","LU0094547139.USD","BK4533","LU0964807845.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121328294","title":"Stock Track | INSILICO Soars 5.19% Intraday on Upcoming AI Drug Research Presentation at AACR 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1121328294","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121328294?lang=en_us&edition=fundamental","pubTime":"2026-04-22 10:19","pubTimestamp":1776824366,"startTime":"0","endTime":"0","summary":"INSILICO's stock surged 5.19% during the morning session, reflecting strong positive investor sentiment.The sharp rise follows the company's announcement that it will present four generative...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190691671","title":"INSILICO Shares Rise Nearly 4% in Early Trading on Upcoming AACR 2026 Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=1190691671","media":"Stock News","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190691671?lang=en_us&edition=fundamental","pubTime":"2026-04-22 10:16","pubTimestamp":1776824204,"startTime":"0","endTime":"0","summary":"INSILICO (03696) saw its shares climb close to 4% during the morning session. At the time of writing, the stock was up 2.49%, trading at HKD 70.05, with a turnover of HKD 98.23 million. The positive...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK4588","AIPO","ARTY","BK4585","CHAT","VXUS","AGIX","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629706151","title":"3 Asian Value Stocks Trading At Up To 49.1% Below Intrinsic Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2629706151","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629706151?lang=en_us&edition=fundamental","pubTime":"2026-04-22 06:05","pubTimestamp":1776809100,"startTime":"0","endTime":"0","summary":"As geopolitical tensions in the Middle East show signs of easing, Asian markets are experiencing a cautious rebound, buoyed by optimism around diplomatic progress and solid economic data from China. In this environment, identifying undervalued stocks becomes essential for investors seeking opportunities amid fluctuating market sentiment.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-853/microport-scientific-shares/news/3-asian-value-stocks-trading-at-up-to-491-below-intrinsic-es","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-853/microport-scientific-shares/news/3-asian-value-stocks-trading-at-up-to-491-below-intrinsic-es","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0057025933.USD","LU2458330169.SGD","LU0719512351.SGD","BK4581","LU0157215616.USD","BK4528","LU0238689110.USD","CRMG","BK4567","LU0267386448.USD","LU1496350502.SGD","LU0354030511.USD","BK4532","LU0820561818.USD","IE00BQXX3D17.EUR","LU0472753341.HKD","LU1551013342.USD","BK4613","LU1551013425.SGD","LU1720051108.HKD","LU1064131342.USD","LU0130102774.USD","LU2756315318.SGD","LU0069063385.USD","LU0689626769.HKD","LU0048573561.USD","LU1823568750.SGD","LU0353189763.USD","BK4561","LU0187121727.USD","LU0820561909.HKD","BK4598","LU0642271901.SGD","IE00BQXX3F31.USD","BK1141","BK4527","BKEAY","LU2361044865.SGD","LU0127658192.USD","LU1366333091.USD","LU1496350171.SGD","LU0310799852.SGD","LU0742534661.SGD","LU1791710400.SGD","LU0211328371.USD","LU0124676726.USD","LU2361045086.USD","LU2357305700.SGD","LU0109392836.USD","LU0251131958.USD","LU2361044949.HKD","LU1989764748.USD","IE00B19Z8W00.USD","LU0354030438.USD","LU2265009873.SGD","00023","LU1951200564.SGD","BK4608","LU2286300806.USD","LU0082616367.USD","BK4023","LU0006306889.USD","LU0289739343.SGD","IE00BQXX3C00.GBP","BK4588","BK4585","LU0648001328.SGD","LU2264538146.SGD","LU0689472784.USD","LU1989764664.SGD","LU1720051017.SGD","LU1046421795.USD","LU0234572021.USD","BK7142","LU0081259029.USD","LU1201861249.SGD","BK4535","LU0106261372.USD","LU2458330243.SGD","LU1791710582.SGD","LU0477156797.USD","LU0511384066.AUD","LU2236285917.USD","BK4543","LU0130518102.USD","LU0889565833.HKD","LU1548497426.USD","BK4579","IE00BJTD4N35.SGD","LU0130517989.USD","LU2244417387.USD","IE00B19Z9505.USD","LU0234570918.USD","LU0980610538.SGD","LU1267930813.SGD","IE00B19Z8X17.USD","LU0889566641.SGD","IE00BJTD4V19.USD","BK4548","LU1235294995.USD","IE00BKVL7J92.USD","LU2247934214.USD","LU1814569148.SGD","LU0528227936.USD","LU1803068979.SGD","LU0943347566.SGD","LU0648000940.SGD","BK4550","LU0130103400.USD","LU1316542783.SGD","LU2087625088.SGD","LU0557290698.USD","LU1201861165.SGD","LU1267930490.SGD","LU0211327993.USD","IE00BZ1G4Q59.USD","BK4505","LU0820562030.AUD","LU0198837287.USD","LU2461242641.AUD","LU2756315664.SGD","LU0792757196.USD","03696","LU1923623000.USD","LU0251142724.SGD","BK4607","LU0289961442.SGD","BK4538","LU1988902786.USD","LU1804176565.USD","00853","LU0353189680.USD","BK4534","LU1951198990.SGD","LU0477156953.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629034492","title":"Insilico Medicine forms Longevity Board, names Lilly’s Andrew Adams chairman","url":"https://stock-news.laohu8.com/highlight/detail?id=2629034492","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629034492?lang=en_us&edition=fundamental","pubTime":"2026-04-21 21:07","pubTimestamp":1776776855,"startTime":"0","endTime":"0","summary":"Insilico Medicine formed Longevity Board to guide AI-driven aging research and drug discovery.Andrew Adams was named chairman; he is Group Vice President, Molecular Discovery at Eli Lilly.Board mandate covers aging biomarkers, dual-purpose targets tied to aging and disease, and clinical validation using biomarkers and foundation models.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nNDL50MrKM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629464034","title":"Press Release: Insilico Medicine Announces Industry's First Longevity Board to Accelerate AI-Driven Aging Research for Drug Discovery","url":"https://stock-news.laohu8.com/highlight/detail?id=2629464034","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629464034?lang=en_us&edition=fundamental","pubTime":"2026-04-21 21:06","pubTimestamp":1776776760,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., April 21, 2026 /PRNewswire/ -- Insilico Medicine , a clinical-stage generative artificial intelligence -driven biotechnology company, today announced the strategic formation of the industry's first Longevity Board . The initiative provides scientific oversight and strategic guidance for AI-enabled aging research and drug discovery, accelerating the development of therapeutics that target the fundamental biological processes of aging and advancing a shift from reactive disease care to proactive healthspan and peakspan extension. The Board will oversee the work in life models, biomarkers of aging, identification of dual-purpose targets implicated in aging, longevity and disease, and clinical development validating the effects of therapeutics on the hallmarks of aging using biomarkers and foundation models.The initial board is composed of high-profile scientists involved in aging and disease research including:. -- Longevity Board Chairman: Andrew Adams, PhD, Group Vice ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTY","03696","BK1141","AAQC","AGIX","AIPO","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100501409","title":"Insilico Medicine Surges Over 6% on AI-Driven Drug Discovery Advancements and Strategic Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=1100501409","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100501409?lang=en_us&edition=fundamental","pubTime":"2026-04-20 09:58","pubTimestamp":1776650338,"startTime":"0","endTime":"0","summary":"Insilico Medicine (03696) rose more than 6% in Hong Kong trading. At the time of writing, the stock was up 6.74% to HK$64.9, with a turnover of HK$131 million. The increase follows recent company...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01477","03347","CHAT","AIPO","LU1820825898.SGD","BK0028","VXUS","ARTY","BK1141","BK4588","BK1191","BK0216","BK1576","BK0077","BK0174","BK1574","300347","LU1146622755.USD","BK1583","BK4585","03696","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148602503","title":"Stock Track | Insilico Medicine Soars 8.47% Intraday on AACR Pan-KRAS Inhibitor Research Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=1148602503","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148602503?lang=en_us&edition=fundamental","pubTime":"2026-04-20 09:41","pubTimestamp":1776649307,"startTime":"0","endTime":"0","summary":"Insilico Medicine's stock surged 8.47% during intraday trading on Monday, reflecting strong investor interest in the company's latest research developments.The sharp rise follows the company's...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142067138","title":"Insilico Medicine grants 3.71 million RSUs to employees under Post-IPO incentive plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1142067138","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142067138?lang=en_us&edition=fundamental","pubTime":"2026-04-14 20:21","pubTimestamp":1776169309,"startTime":"0","endTime":"0","summary":"On 14 April 2026, Insilico Medicine announced the award of 3.71 million restricted share units (RSUs) to eligible employees under its Post-IPO RSU Scheme, in compliance with Rule 17.06A of the Hong...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104119070","title":"INSILICO Grants 3.7069 Million Restricted Share Units","url":"https://stock-news.laohu8.com/highlight/detail?id=1104119070","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104119070?lang=en_us&edition=fundamental","pubTime":"2026-04-14 20:08","pubTimestamp":1776168501,"startTime":"0","endTime":"0","summary":"INSILICO (03696) announced that on April 14, 2026, the Board of Directors resolved to grant 3.7069 million restricted share units to eligible individuals under the terms of the post-initial public offering restricted share unit plan, subject to acceptance by the grantees.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627944561","title":"Insilico Medicine grants 3,706,886 RSUs under post-IPO incentive scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=2627944561","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627944561?lang=en_us&edition=fundamental","pubTime":"2026-04-14 20:02","pubTimestamp":1776168133,"startTime":"0","endTime":"0","summary":"Insilico Medicine granted 3,706,886 restricted share units under its post-IPO RSU scheme on April 14, 2026.RSUs carried zero purchase price; shares closed at HK$ 60.35 on grant date.Special awards covered 3,548,764 RSUs for 24 employees; vesting set quarterly in equal tranches or split between a second-anniversary tranche and quarterly vesting thereafter.Regular awards covered 158,122 RSUs for 38 employees; vesting set at one-third on first anniversary with quarterly vesting thereafter.Unvested RSUs can lapse under specified circumstances such as confidentiality breaches or competitive outside employment.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insilico Medicine Cayman Topco published the original content used to generate this n","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nNDL5KnJw9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163319502","title":"INSILICO: No Change in Share Capital for March 2026; Public Float Meets 15% Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=1163319502","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163319502?lang=en_us&edition=fundamental","pubTime":"2026-04-09 17:03","pubTimestamp":1775725389,"startTime":"0","endTime":"0","summary":"InSilico Medicine Cayman TopCo (INSILICO) released its Monthly Return for Equity Issuer for the period ended 31 March 2026, confirming stable share capital metrics and continued compliance with Hong...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181951307","title":"Stock Track | Insilico Medicine Soars 8.98% Intraday on Preclinical Candidate Nomination and Eli Lilly Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=1181951307","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181951307?lang=en_us&edition=fundamental","pubTime":"2026-04-09 10:28","pubTimestamp":1775701728,"startTime":"0","endTime":"0","summary":"Insilico Medicine's stock soared 8.98% during intraday trading, reflecting strong investor optimism following significant company announcements.The surge is primarily attributed to the company's...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121047925","title":"Insilico Medicine Shares Surge Over 9% in Morning Session Following Nomination of Promising NR3C1 Antagonist","url":"https://stock-news.laohu8.com/highlight/detail?id=1121047925","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121047925?lang=en_us&edition=fundamental","pubTime":"2026-04-09 10:26","pubTimestamp":1775701585,"startTime":"0","endTime":"0","summary":"Insilico Medicine (03696) saw its shares rise more than 9% during the morning trading session. At the time of writing, the stock was up 4.49%, trading at HK$61.7 with a turnover of HK$130 million....","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","03696","BK1141","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157401535","title":"Stock Track | INSILICO Soars 11.79% Intraday on $2.75 Billion Eli Lilly AI Drug Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=1157401535","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157401535?lang=en_us&edition=fundamental","pubTime":"2026-04-01 11:31","pubTimestamp":1775014311,"startTime":"0","endTime":"0","summary":"INSILICO's stock price surged 11.79% during intraday trading on Wednesday, marking a significant upward movement for the AI-driven biotech company.The sharp rise follows the announcement of a major...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://insilico.com","stockEarnings":[{"period":"1week","weight":0.1466},{"period":"1month","weight":0.3681},{"period":"3month","weight":0.143},{"period":"6month","weight":1.9751},{"period":"ytd","weight":0.9265}],"compareEarnings":[{"period":"1week","weight":-0.0182},{"period":"1month","weight":0.034},{"period":"3month","weight":-0.0312},{"period":"6month","weight":-0.0094},{"period":"1year","weight":0.1741},{"period":"ytd","weight":0.0111}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"InSilico Medicine Cayman TopCo is a company principally engaged in the research and development of artificial intelligence in pharmaceuticals. The Company is engaged in the research and development of drug discovery engines. In addition, the Company is engaged in the copabdrug discovery and development of disease target identification, generation of novel molecules data, and predicting clinical trial outcomes.","exchange":"SEHK","name":"INSILICO","nameEN":"INSILICO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"INSILICO(03696),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest INSILICO(03696) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"INSILICO,03696,INSILICO股票,INSILICO股票老虎,INSILICO股票老虎国际,INSILICO行情,INSILICO股票行情,INSILICO股价,INSILICO股市,INSILICO股票价格,INSILICO股票交易,INSILICO股票购买,INSILICO股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"INSILICO(03696),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest INSILICO(03696) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}